Congress Asset Management Co. Boosts Position in Integer Holdings Co. (NYSE:ITGR)

Congress Asset Management Co. lifted its position in Integer Holdings Co. (NYSE:ITGR - Free Report) by 3.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 488,785 shares of the medical equipment provider's stock after buying an additional 18,303 shares during the quarter. Congress Asset Management Co. owned about 1.46% of Integer worth $63,542,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. GSA Capital Partners LLP bought a new position in Integer in the 1st quarter worth about $786,000. Blue Trust Inc. boosted its stake in Integer by 460.4% during the second quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider's stock valued at $658,000 after buying an additional 4,636 shares during the last quarter. UniSuper Management Pty Ltd purchased a new stake in shares of Integer in the first quarter worth approximately $976,000. Moloney Securities Asset Management LLC bought a new position in Integer in the first quarter worth approximately $927,000. Finally, Earnest Partners LLC boosted its position in shares of Integer by 3.2% in the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider's stock worth $139,911,000 after purchasing an additional 37,340 shares in the last quarter. 99.29% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have weighed in on ITGR shares. Oppenheimer began coverage on Integer in a report on Tuesday, July 16th. They set an "outperform" rating and a $135.00 price target on the stock. Piper Sandler reaffirmed an "overweight" rating and set a $140.00 target price (up from $125.00) on shares of Integer in a research report on Friday, October 25th. Truist Financial reduced their price objective on Integer from $150.00 to $147.00 and set a "buy" rating for the company in a research report on Friday, October 25th. Citigroup boosted their target price on shares of Integer from $124.00 to $130.00 and gave the company a "neutral" rating in a research note on Tuesday, October 1st. Finally, KeyCorp upped their price target on shares of Integer from $139.00 to $144.00 and gave the company an "overweight" rating in a report on Tuesday, October 15th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $139.75.

Integer Trading Down 4.4 %

Shares of NYSE:ITGR traded down $5.69 during midday trading on Thursday, reaching $124.25. 285,519 shares of the company's stock were exchanged, compared to its average volume of 312,152. The stock has a market cap of $4.16 billion, a price-to-earnings ratio of 44.96, a P/E/G ratio of 1.80 and a beta of 1.08. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The firm's 50 day simple moving average is $128.00 and its two-hundred day simple moving average is $121.27. Integer Holdings Co. has a fifty-two week low of $79.68 and a fifty-two week high of $133.53.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.07. Integer had a return on equity of 11.48% and a net margin of 6.31%. The firm had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. During the same period in the prior year, the business posted $1.27 earnings per share. The firm's revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, sell-side analysts forecast that Integer Holdings Co. will post 5.3 EPS for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.